
FINAL TRADES FEB. 4, 2015
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:

Jim Lebenthal: Buy BP Josh Brown: Buy Disney Jon Najarian: Buy Colgate-Palmolive Pete Najarian: Buy Goodyear Tire FOR THE RECORD - TRADER DISCLOSURES PETE NAJARIAN Long AAPL, BABA, DB, JPM,
LOCO, KKR, LLY, MRK, BAC, BMY,PFE, KO, he is long calls AAL, BABA, COP, DAL, DIS, DNKN, EBAY, FCX, GILD, GT,IAG, ISIL, MCD, MRVC, PEP, RG, SYY, UAL, XLE, XLF, SPY, EWG, he is long puts BHP
JON NAJARIAN Long ABT, AN, ADP, ATVI, AUY, BRCM, BYD calls, CAR, EOG, EXC, GNW puts, HUN, IMAX,INFN, MW, NSAM, OKE, POST, RAD, SIRI, TWTR, TWX, XLE, today he bought GNW puts JOSH BROWN Long
AAPL, DE, DGRE, DNKN, FCX, FSLR, GBX, MBLY, SPWR, TNET, TWTR, VWO, XLE JIM LEBENTHAL Long AAPL, ATK, BP, C, DCO, EEQ, GAIA, GM, IBM, INTC, JCP, MPC, ORBC, PFE, SJT,SPLS, TGT, WGO YARON
WERBER Citigroup Global Markets Inc. owns a position of 1 million USD or more in the debt securities of Gilead Sciences Inc Citigroup Global Markets Inc. or an affiliate received
compensation for products and services other than investment banking services from Gilead Sciences Inc in the past 12 months Citigroup Global Markets Inc. currently has, or had within the
past 12 months, the following as clients, and the services provided were non-investment banking,securities-related: Gilead Sciences Inc. Citigroup Global Markets Inc. currently has, or
hadwithin the past 12 months, the following as clients, and the services provided were non-investment banking,non-securities-related: Gilead Sciences Inc. Analysts' compensation is
determined based upon activities and services intended to benefit the investor clients of Citigroup Global Markets Inc. and its affiliates ("the Firm"). Like all Firmemployees,
analysts receive compensation that is impacted by overall firm profitability which includes investment banking revenues. The Firm is a market maker in the publicly traded equity securities
of Gilead Sciences Inc. PAUL MEEKS Long AAPL, DAL, FFIV, FB, BWA, ASH, MDVN, CVS, UNP, ALK